| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Outline of Final Research Achievements |
We made a hypothesis that syndecan-4 elevated in chronic lung disease infant after chorioanmionatis and that the difference in expression of syndecan-4 in early time after delivery could reflect degree of chronic lung disease in preterm infants.
First, we measured syndecan-4 in term infants for reference value. We tried the measurement of syndecan-4 in preterm infants, however,umbilical cord blood or residual serum for this study were too insufficient to analyze even after one year extension of the research.
|
